Patients with the Bundibugyo strain of Ebola have started receiving experimental treatments in a clinical trial that aims to improve care for the rare viral disease, which has killed more than 500 people in Democratic Republic of Congo.
Patients with the Bundibugyo strain of Ebola have started receiving experimental treatments in a clinical trial that aims to improve care for the rare viral disease, which has killed more than 500 people in Democratic Republic of Congo.
<iframe src="https://statesidedaily.com/embed/cluster/9907ac166ef87ae1ac63d915145343bd1d60a225" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="First Trial of Experimental Bundibugyo Ebola Treatments Begins in Congo as Death Toll Tops 100"></iframe>
